Clinical outcome in relation to lymph node histology and TCR analysis
Course of disease . | Patients, no. . | Histology (N3), no. . | Clonal TCR-β-R, no. . | Clonal TCR-γ-R, no. . |
|---|---|---|---|---|
| CR | 5 | 0 | 0 | 0 |
| SD | 6 | 3 | 4 | 4 |
| PD | 3 | 1 | 3 | 3 |
| DOD | 19 | 15 | 19 | 18 |
| D | 3 | 3 | 2 | 2 |
| Total | 36 | 21 | 29 | 27 |
Course of disease . | Patients, no. . | Histology (N3), no. . | Clonal TCR-β-R, no. . | Clonal TCR-γ-R, no. . |
|---|---|---|---|---|
| CR | 5 | 0 | 0 | 0 |
| SD | 6 | 3 | 4 | 4 |
| PD | 3 | 1 | 3 | 3 |
| DOD | 19 | 15 | 19 | 18 |
| D | 3 | 3 | 2 | 2 |
| Total | 36 | 21 | 29 | 27 |
CR indicates complete remission; SD, stable disease; PD, progressive disease; DOD, died of disease; D, died, unrelated to disease; TCR-β-R, TCR-β rearrangement; TCR-γ-R, TCR-γ rearrangement; N3, lymph node involvement.